Resorufin - a lead for a new protein kinase CK2 inhibitor

Poster   Feb 21, 2009

 
Resorufin - a lead for a new protein kinase CK2 inhibitor
 
View Poster
 
 

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 

This content appears on:

Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

OTHER POSTERS

Applications of chemically modified synthetic guide RNA for CRISPR-Cas9 genome editing

Poster

Our results indicate that MS modifications are required for experiments with co-electroporation of Cas9 mRNA and synthetic gRNA, yet have no impact on editing efficiency when delivered with lipid-based transfection reagents.

READ MORE

Novel lead optimization strategy of BACE I inhibitors for the treatment of Alzheimer’s disease by Quantitative Structure-Activity Relationship (QSAR) and Physiologically-Based Pharmacokinetics (PBPK) modeling

Poster

In this study, we introduce an innovative in silico-based high throughput lead optimization strategy with QSAR and PBPK modelings using StarDrop™, ADMET predictor® and GastroPlus®.

READ MORE

Automating Mass Spectrometry-Based Quantitative Glycomics using Tandem Mass Tag (TMT) Reagents with SimGlycan

Poster

One of the emerging trends in glycomics research is the innovation related to accurate MS based quantitative analysis of glycans.

READ MORE

 

Comments | 0 ADD COMMENT